Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate Cancer.
Wolfgang P FendlerManuel WeberAmir IravaniMichael S HofmanJérémie CalaisJohannes CzerninHarun IlhanFred SaadEric J SmallMatthew R SmithPaola M PerezThomas A HopeIsabel RauscherAnil LondheAngela Lopez-GitlitzShinta ChengTobias MaurerKen HerrmannMatthias EiberBoris HadaschikPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2019)
PSMA-PET detected any disease in nearly all patients and M1 disease in 55% of patients previously diagnosed with nmCRPC, including subgroups with PSADT of ≤10 months and Gleason score of ≥8. The value of PSMA-PET imaging for treatment guidance should be tested in future studies.